Predicting Relapse After Cocaine Inpatient Cessation (QUIT-COC)
Prospective Prediction of Cocaine Relapse After Inpatient Cessation by Combining Functional Imaging and Neuropsychological Biomarkers With Craving and Impulsivity Measures
Sponsor: Assistance Publique - Hôpitaux de Paris
This observational or N/A phase trial investigates Cocaine Dependence and Cocaine Use Disorder and is currently completed. Assistance Publique - Hôpitaux de Paris leads this study, which shows 11 recorded versions since 2015 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Apr 2023 — Jul 2024 [monthly]
Completed
Status: Terminated → Completed
-
Sep 2022 — Apr 2023 [monthly]
Terminated
-
Mar 2022 — Sep 2022 [monthly]
Terminated
Status: Recruiting → Terminated
▶ Show 6 earlier versions
-
Mar 2021 — Mar 2022 [monthly]
Recruiting
Status: Unknown Status → Recruiting
-
Jan 2021 — Mar 2021 [monthly]
Unknown Status
-
Oct 2018 — Jan 2021 [monthly]
Unknown Status
Status: Recruiting → Unknown Status
-
Jun 2018 — Oct 2018 [monthly]
Recruiting
-
Apr 2018 — Jun 2018 [monthly]
Recruiting
Phase: NA → None
-
Jan 2017 — Apr 2018 [monthly]
Recruiting NA
First recorded
Feb 2015
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Assistance Publique - Hôpitaux de Paris
For direct contact, visit the study record on ClinicalTrials.gov .